Ben Mc Larney,1 Mijin Kim,1 Sheryl Roberts,1 Magdalena Skubal,1 Hsiao-Ting Tsu,1 Anuja Ogirala,1 Nagavarakishore Pillarsetty,1 Daniel Heller,1 Jason S. Lewis,1 Jan Grimm1
1Memorial Sloan-Kettering Cancer Ctr. (United States)
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The advantages of shortwave infrared (SWIR, 900-1700 nm) imaging over NIR (650-900 nm) include reduced tissue optical aberrations, increased depth penetration along with improved resolution and contrast. Preclinical SWIR imaging has focused on system development and novel fluorophore development with a goal of targeted tumor resection for clinical translation. Clinical SWIR imaging has focused on indocyanine green (ICG) and the enhanced permeability and retention effect for resection with significant advantages. In this work we preclinically validate the pH low insertion peptide (pHLIP) conjugated to ICG (pHLIP ICG, currently in clinical trials) as a suitable cancer targeted fluorophore for cancer resection.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Ben Mc Larney, Mijin Kim, Sheryl Roberts, Magdalena Skubal, Hsiao-Ting Tsu, Anuja Ogirala, Nagavarakishore Pillarsetty, Daniel Heller, Jason S. Lewis, Jan Grimm, "Shortwave infrared preclinical tumor screening and resection via pHLIP ICG (Conference Presentation)," Proc. SPIE PC12398, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications XIV, PC1239804 (17 March 2023); https://doi.org/10.1117/12.2655598